The optimization of recombinant antibody production within Chinese hamster ovary (CHO) cells presents a paramount challenge to the biopharmaceutical industry. A variety of strategies are employed maximize antibody titer, comprising process parameter optimization, media optimization, and the use of perfusion technologies. Fine-tuning culture condi